DAGAVOC-10
March 28, 2026
EMFOSIK-25
March 28, 2026
EMFOSIK-10
₹2,950.00
Composition:
Empagliflozin 10 mg
Packaging Detail:
10 x 10
Description
A tablet containing Empagliflozin, an SGLT2 inhibitor for type 2 diabetes management. It helps lower blood sugar by increasing glucose excretion in urine and has proven cardiovascular benefits.
Indications
Indications
-
Type 2 diabetes mellitus.
-
To reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.
-
Heart failure with reduced ejection fraction.
Side Effects
Side Effects
-
Genital fungal infections.
-
Urinary tract infections.
-
Increased urination.
-
Dehydration and low blood pressure.
-
Rare risk of ketoacidosis.
Reviews 0
Related products
-
CEFIMOX-CV 325
₹1,900.00 -
ZYMEMEL-AC
₹1,250.00 -
ACEFOX-TH
₹1,900.00
Reviews
There are no reviews yet.